Study of the Breast Milk Microbiota and Its Influence on the Development of Early and Late Neonatal Bacterial Sepsis Under Three Months of Age. (MINEOS)

P

Public Assistance-Hospitals of Marseille (AP-HM)

Status

Enrolling

Conditions

Neonatal Sepsis

Treatments

Other: Collection of breast milk

Study type

Interventional

Funder types

Other

Identifiers

NCT05490498
2021-11
ID-RCB (Other Identifier)

Details and patient eligibility

About

Breast milk contains many microorganisms including bacteria that are beneficial to health (probiotics), but also bacteria that are generally considered pathogenic. Several studies have described an increased risk of infections due to pathogenic germs in breast milk in premature newborns whose digestive system is immature and whose digestive flora is modified by repeated antibiotic treatments. However, a breastfed baby is better protected against infectious diseases than a bottle-fed baby. The objective of this study is to define the breast milk microbiota of infants with confirmed early or late neonatal bacterial infection compared to the breast milk microbiota of infants with no evidence of bacterial infection. For that purpose, an exploration will be performed using the principle of "Microbial Culturomics" and targeted metagenomics (16S ribosomal RNA gene sequencing).

Enrollment

75 estimated patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

Breastfeeding mothers of infants:

  • Aged 1 to 89 days consulting in hospitals in the Marseille area (Assistance Publique des Hôpitaux de Marseille: Hôpital de la Timone-enfants and Hôpital Nord),
  • Suspected neonatal bacterial infection due to the presence of fever (rectal or axillary temperature > 38°C),
  • In whom bacteriological samples have been taken (cerebrospinal fluid, joint fluid, blood cultures, urine),
  • Patients affiliated or benefiting from a social security system.

Exclusion criteria

  • Exclusive formula milk feeding
  • Opposition of legal guardians
  • No bacteriological sample to prove infant infection
  • No confirmation of fever by standardized method
  • Opposition to participating in the study
  • Neonatal hospitalization > 48 hours for management of prematurity.
  • Severe congenital malformations in the infant.
  • Antibiotic treatment for a concomitant bacterial infection in the infant.

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

75 participants in 1 patient group

Breastfeeding mother
Experimental group
Description:
Breastfeeding mother with infants between 1 and 89 days of age who presented with suspected neonatal bacterial sepsis due to the presence of a fever.
Treatment:
Other: Collection of breast milk

Trial contacts and locations

0

Loading...

Central trial contact

Lucile LESAGE

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems